Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Burford Capital Limited (BUR.LN)

Burford Capital Limited (BUR.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
In a blow to Milei, a US judge orders Argentina to turn over its majority stake in state oil company

The fate of Argentina’s state-run oil company has been thrown into doubt as a U.S. judge ordered the cash-strapped country to give up its 51% controlling stake in YPF

BUR.LN : 689.000 (-3.09%)
Intended Purchases of Burford Capital Ordinary Shares by Employee Benefit Trust

INTENDED PURCHASES OF ORDINARY SHARES BY EMPLOYEE BENEFIT TRUST

BUR.LN : 689.000 (-3.09%)
BUR : 9.20 (-4.66%)
Burford Capital Notification of Transaction by Person Discharging Managerial Responsibilities (PDMR)

GUERNSEY, the CHANNEL ISLANDS / ACCESSWIRE / November 25, 2022 / Burford Capital Limited ("Burford"), the leading global finance and asset management firm focused on law, has been notified of certain purchases...

BUR.LN : 689.000 (-3.09%)
BUR : 9.20 (-4.66%)
Burford Capital appointment of Joint Corporate Broker

GUERNSEY / ACCESSWIRE / November 16, 2022 / Burford Capital Limited, the leading global finance and asset management firm focused on law, is pleased to announce the appointment of Berenberg as Joint Corporate...

BUR.LN : 689.000 (-3.09%)
BUR : 9.20 (-4.66%)
Burford Capital Sterling Conversion Rate for 2022 Interim Dividend

GUERNSEY / ACCESSWIRE / November 9, 2022 / Burford Capital Limited, the leading global finance and asset management firm focused on law, today announces the Sterling conversion rate for its previously...

BUR.LN : 689.000 (-3.09%)
BUR : 9.20 (-4.66%)
Burford Capital Releases 2022 GC Survey Results

New research reveals growing business impact of in-house lawyers and legal departments as they increasingly generate cash recoveries

BUR.LN : 689.000 (-3.09%)
BUR : 9.20 (-4.66%)
Burford Capital Limited Announces Burford Capital-Report on Class Action Recoveries

New research shows companies with large claims recover more and preserve budgets by using legal finance as part of their class action opt out strategies

BUR.LN : 689.000 (-3.09%)
BUR : 9.20 (-4.66%)
Burford Capital Appoints Jordan Licht as Chief Financial Officer

GUERNSEY / ACCESSWIRE / September 6, 2022 / Burford Capital Limited, the leading global finance and asset management firm focused on law, today announces that Jordan Licht has been appointed as its Chief...

BUR.LN : 689.000 (-3.09%)
RITM : 10.01 (-4.21%)
BUR : 9.20 (-4.66%)
Burford Capital Reports First Half 2022 Results

GUERNSEY / ACCESSWIRE / August 9, 2022 / Burford Capital Limited (NYSE:BUR)(LSE:BUR), the leading global finance and asset management firm focused on law, today announces its financial results for the...

BUR.LN : 689.000 (-3.09%)
BUR : 9.20 (-4.66%)
Burford Capital Appoints Dr. Rukia Baruti as an Independent Non-Executive Director

GUERNSEY / ACCESSWIRE / August 9, 2022 / Burford Capital Limited, the leading global finance and asset management firm focused on law, is pleased to announce the appointment of Dr. Rukia Baruti as an independent...

BUR.LN : 689.000 (-3.09%)
BUR : 9.20 (-4.66%)

Barchart Exclusives

Novo Nordisk Stock Is Deeply Oversold on Weight Loss Drug Fail. Should You Buy the Dip?
Novo Nordisk stock tanks as CagriSema appears inferior to Eli Lilly’s competing weight-loss drug in a late-stage trial. But NVO shares are still worth buying at current levels. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar